MedTrace Logo

Clinical Trial Readiness for the Dystroglycanopathies

NCT00313677 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 190

Last updated 2025-07-30

No results posted yet for this study

Summary

The purpose of the study is to describe the early signs and symptoms of the dystroglycanopathies, and to gather information that will be required for future clinical trials.

Conditions

  • Muscular Dystrophy

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Katherine Mathews

    lead OTHER

Principal Investigators

  • Katherine Mathews, M.D. · University of Iowa

  • Kevin Campbell, Ph.D. · Co-Investigator

  • Steven A. Moore, M.D. Ph.D. · Co-Investigator

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2030-07-31
Completion
2030-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00313677 on ClinicalTrials.gov